It is well known that obesity can modify the metabolism of high-density lipoproteins, including apolipoprotein A1, and could therefore increase AAA1 IgG levels over the positivity limit, indirectly enhancing cardiovascular disease risk [19,20]. The gene discussed is APOA1; the disease is cardiovascular disorder.